Small airways obstruction and its risk factors in the Burden of Obstructive Lung Disease (BOLD) study: a multinational cross-sectional study

医学 疾病 横断面研究 跨国公司 疾病负担 重症监护医学 阻塞性肺病 内科学 肺病 肺病 肺 环境卫生 病理 业务 财务
作者
Ben Knox‐Brown,Jaymini Patel,James Potts,Rana Ahmed,Althea Aquart-Stewart,Hamid Hacene Cherkaski,Meriam Denguezli,M. Elbiaze,Asma Elsony,Frits M.E. Franssen,Mohammed Al Ghobain,Imed Harrabi,Christer Janson,Rain Jögi,Sanjay Kamlakar Juvekar,Hervé Lawin,David M. Mannino,Kevin J. Mortimer,Asaad Ahmed Nafees,Rune Nielsen
出处
期刊:The Lancet Global Health [Elsevier BV]
卷期号:11 (1): e69-e82 被引量:51
标识
DOI:10.1016/s2214-109x(22)00456-9
摘要

Background Small airways obstruction is a common feature of obstructive lung diseases. Research is scarce on small airways obstruction, its global prevalence, and risk factors. We aimed to estimate the prevalence of small airways obstruction, examine the associated risk factors, and compare the findings for two different spirometry parameters. Methods The Burden of Obstructive Lung Disease study is a multinational cross-sectional study of 41 municipalities in 34 countries across all WHO regions. Adults aged 40 years or older who were not living in an institution were eligible to participate. To ensure a representative sample, participants were selected from a random sample of the population according to a predefined site-specific sampling strategy. We included participants' data in this study if they completed the core study questionnaire and had acceptable spirometry according to predefined quality criteria. We excluded participants with a contraindication for lung function testing. We defined small airways obstruction as either mean forced expiratory flow rate between 25% and 75% of the forced vital capacity (FEF 25–75 ) less than the lower limit of normal or forced expiratory volume in 3 s to forced vital capacity ratio (FEV 3 /FVC ratio) less than the lower limit of normal. We estimated the prevalence of pre-bronchodilator (ie, before administration of 200 μg salbutamol) and post-bronchodilator (ie, after administration of 200 μg salbutamol) small airways obstruction for each site. To identify risk factors for small airways obstruction, we performed multivariable regression analyses within each site and pooled estimates using random-effects meta-analysis. Findings 36 618 participants were recruited between Jan 2, 2003, and Dec 26, 2016. Data were collected from participants at recruitment. Of the recruited participants, 28 604 participants had acceptable spirometry and completed the core study questionnaire. Data were available for 26 443 participants for FEV 3 /FVC ratio and 25 961 participants for FEF 25–75 . Of the 26 443 participants included, 12 490 were men and 13 953 were women. Prevalence of pre-bronchodilator small airways obstruction ranged from 5% (34 of 624 participants) in Tartu, Estonia, to 34% (189 of 555 participants) in Mysore, India, for FEF 25–75 , and for FEV 3 /FVC ratio it ranged from 5% (31 of 684) in Riyadh, Saudi Arabia, to 31% (287 of 924) in Salzburg, Austria. Prevalence of post-bronchodilator small airways obstruction was universally lower. Risk factors significantly associated with FEV 3 /FVC ratio less than the lower limit of normal included increasing age, low BMI, active and passive smoking, low level of education, working in a dusty job for more than 10 years, previous tuberculosis, and family history of chronic obstructive pulmonary disease. Results were similar for FEF 25–75 , except for increasing age, which was associated with reduced odds of small airways obstruction. Interpretation Despite the wide geographical variation, small airways obstruction is common and more prevalent than chronic airflow obstruction worldwide. Small airways obstruction shows the same risk factors as chronic airflow obstruction. However, further research is required to investigate whether small airways obstruction is also associated with respiratory symptoms and lung function decline. Funding National Heart and Lung Institute and Wellcome Trust. Translations For the Dutch, Estonian, French, Icelandic, Malay, Marathi, Norwegian, Portuguese, Swedish and Urdu translations of the abstract see Supplementary Materials section.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
WZH完成签到,获得积分10
刚刚
Du_u20230228完成签到,获得积分10
1秒前
2秒前
2秒前
2秒前
szh发布了新的文献求助10
3秒前
懒得起名发布了新的文献求助10
3秒前
帅气雨安完成签到,获得积分10
4秒前
科研通AI6.2的应助被海鹏采纳,获得10
4秒前
4秒前
4秒前
5秒前
kuoping完成签到,获得积分0
5秒前
rabada_123发布了新的文献求助50
6秒前
七塔蹦蹦蹦完成签到,获得积分10
6秒前
xixi的应助被不想上班了采纳,获得10
7秒前
小胖胖发布了新的文献求助10
7秒前
hw发布了新的文献求助10
8秒前
zyh666完成签到,获得积分10
8秒前
马嘎嘎发布了新的文献求助10
9秒前
小马甲的应助被szh采纳,获得10
9秒前
9秒前
vvww完成签到,获得积分10
9秒前
希望天下0贩的0的应助被Re采纳,获得10
10秒前
Ww完成签到,获得积分10
10秒前
11秒前
11秒前
wenbo完成签到,获得积分10
12秒前
完美芯完成签到,获得积分10
12秒前
柠檬完成签到 ,获得积分10
12秒前
小恶于发布了新的文献求助10
12秒前
大个的应助被嘎嘎的鸡神采纳,获得10
13秒前
13秒前
活剥的老爸完成签到,获得积分10
13秒前
秋风的应助被烂漫之槐采纳,获得10
13秒前
Hello的应助被抽风而已采纳,获得10
13秒前
14秒前
乐观完成签到 ,获得积分10
14秒前
徐XU完成签到 ,获得积分10
14秒前
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178582
求助须知:如何正确求助?哪些是违规求助? 9569391
关于积分的说明 21804062
捐赠科研通 7773535
什么是DOI,文献DOI怎么找? 3432871
关于科研通互助平台的介绍 2556860
邀请新用户注册赠送积分活动 2478451